Clinical Trials Logo

Filter by:
NCT ID: NCT05751239 Completed - Clinical trials for Family Characteristics

Motives for Desiring Children in Different Sexual-romantic Orientations

Start date: July 3, 2018
Phase:
Study type: Observational

The goal of this cross-sectional study is to compare the motives for the desire to have children in different sexual-romantic orientation. The main question[s] it aims to answer are: - Do all orientations have the same motives for the desire to have children? - What are the preferred methods for having a child for the different orientations Participants will answer an online questionaire . Researchers will compare the different orientations to see if there are differences.

NCT ID: NCT05751057 Recruiting - Clinical trials for Non-ST Elevation Myocardial Infarction (NSTEMI)

The Role of Cardiovascular Magnetic Resonance in Patients With Non-ST- Elevation- Myocardial Infarction

TITAN-MRI
Start date: December 14, 2022
Phase: N/A
Study type: Interventional

The goal of this prospective study is to evaluate the role of cardiovascular magnetic resonance (CMR) in patients with suspected non-ST elevation myocardial infarction (NSTEMI). The main endpoint is the reclassification rate, defined as the number of patients in whom the information provided by pre-angiography CMR affects the revascularization strategy or the final diagnosis. Participants will undergo to CMR before invasive coronary angiography (ICA).

NCT ID: NCT05751031 Recruiting - HIV Infections Clinical Trials

Pregnancy and Neonatal Outcomes Following Antenatal Exposure to Raltegravir: a Pooled Analysis From the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC)

Start date: February 20, 2023
Phase:
Study type: Observational

Raltegravir is the preferred INSTI for for treatment of antiretroviral-naïve pregnant women in the US Perinatal Guidelines, alongside Dolutegravir, and for late pregnancy. There are relatively limited information available on its use during early pregnancy, particularly the peri-conception period. The aim of the study is to assess "real-world" maternal, fetal and newborn outcomes following RAL use during pregnancy through pooled analysis of individual patient data from observational studies participating in the European Pregnancy and Paediatric Infections Cohort Collaboration.

NCT ID: NCT05750862 Active, not recruiting - Astigmatism Clinical Trials

Accuracy of Topography Guided Automatic Marking of the Intraocular Lens (IOL) -Axis

Start date: March 20, 2023
Phase: N/A
Study type: Interventional

In cataract surgery, the opaque lens is replaced by an artificial intraocular lens. The procedure also allows for correction of an refractive error such as myopia, hyperopia or astigmatism. In case of correction of an astigmatism, the axis intraocular lens has to be alligned to the axis of the corneal astigmatism. There are serveral options, the intendet position of the axis can be marked on the cornea, either manually using ink and a special caliper or with an automatic laser device. The aim of this study is to assess the accuracy of topography guided automatic marking of the intended IOL-axis in toric IOL-implantation in femtosecond laser assisted cataract surgery (FLACS)

NCT ID: NCT05748171 Recruiting - Clinical trials for ACUTE LYMPHOBLASTIC LEUKEMIA

A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL

Start date: May 17, 2023
Phase: Phase 2
Study type: Interventional

This prospective, randomized, multicenter, open-label Phase 2 study is designed to evaluate the superiority of InO monotherapy vs ALLR3 after 1 cycle of induction treatment in paediatric participants (between 1 and <18 years) with High Risk (HR) first bone marrow relapse CD22-positive BCP ALL, and to evaluate the safety and tolerability, PK and long-term efficacy. Treatment with study intervention will end after induction therapy; follow-up will continue for up to 5 years from randomization.

NCT ID: NCT05748145 Recruiting - Colorectal Cancer Clinical Trials

Metronidazole as Preoperative Therapy in CRC / FusoMetro-001

Start date: September 11, 2023
Phase: Phase 2
Study type: Interventional

The proposed proof-of concept trial aims at determining the effectiveness of metronidazole in decreasing the Fusobacterium nucleatum load in tissues and possibly on its detrimental effects on tumor cells and tumor microenvironment.

NCT ID: NCT05746806 Recruiting - Clinical trials for Recurrent Prostate Cancer

Trial of Ultrahypofractionated Focal Salvage Radiotherapy for Isolated Prostate Bed Recurrence After Radical Prostatectomy

HypoFocal SRT
Start date: March 29, 2023
Phase: N/A
Study type: Interventional

The main objective of the trial is to explore the efficacy and safety of combining short-term androgen deprivation therapy (ADT) over 6 months to focal ultrahypofractionated salvage radiotherapy (SRT) delivered in 5 fractions to the site of local recurrence within the prostate bed after radical prostatectomy where multiparametric magnetic resonance imaging (mpMRI) and prostate-specific membrane antigen (PSMA) PET/CT are used to precisely identify the local recurrence and compare it to previously published literature.

NCT ID: NCT05745220 Completed - Cornea Clinical Trials

Influence of Silicone Hydrogel Contact Lens Neophyte Wear on Corneal Sensitivity

CSCL
Start date: April 8, 2023
Phase: N/A
Study type: Interventional

Soft contact lenses can affect the ocular surface and sometimes cause intolerance. The aim of this study is to measure corneal sensitivity using the Swiss Liquid Jet aesthesiometer at baseline, after one and after six weeks, in novice daily contact lens wearers.

NCT ID: NCT05743387 Recruiting - Clinical trials for Type 2 Diabetes Mellitus (T2D)

Community-based, eHealth Supported Type 2 Diabetes Care by Lay Village Health Workers in Rural Lesotho

ComBaCaL T2D
Start date: May 13, 2023
Phase: N/A
Study type: Interventional

This cluster-randomized intervention is embedded in the ComBaCaL (Community-Based Chronic disease care Lesotho) cohort study (EKNZ ID AO_2022-00058, clinicaltrials.gov ID NCT05596773, Lesotho NH-REC ID 210-2022), a platform for the investigation of chronic diseases and their management in rural Lesotho that is maintained by local lay chronic care village health workers (CC-VHWs). The overall objective of the ComBaCaL cohort study and nested TwiCs is to assess the impact of eHealthsupported, lay-led chronic disease control measures in rural Lesotho. In this T2D TwiC, the effect, safety and feasibility of a community-based T2D care package (which includes the offer of first-line oral antidiabetic and lipid-lowering treatment for uncomplicated T2D by lay CC-VHWs in comparison to facility-based care after community-based screening and diagnosis) will be evaluated.

NCT ID: NCT05742035 Enrolling by invitation - Clinical trials for Hereditary Hemochromatosis

Quality and Biologic Characteristics of Red Blood Concentrates Obtained From Individuals With Elevated Ferritin.

Start date: January 18, 2023
Phase: N/A
Study type: Interventional

Iron overload in hereditary hemochromatosis (HH) is treated by phlebotomy. It is unclear, if individuals with hyperferritinemia due to hereditary hemochromatosis or to secondary causes are suitable as blood donors. The study investigates hemolysis and several other quality parameters of red blood cell concentrates (RBC) obtained from 80 individual with ferritin >500 ng/mL - due to hereditary hemochromatosis or secondary - and 20 healthy blood donors as control.